Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Aug 15, 2025, 3:59 PM
2.00
3.88%
After-hours: Aug 15, 2025, 07:31 PM EDT
Spero Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 42.89M | 34.72M | 33.05M | 95.52M | 107.52M | 102.29M | 98.83M | 73.3M | 48.91M | 49.02M | 48.53M | 4.97M | 6.95M | 11.2M | 18.26M | 17.42M | 18.35M | 14.93M |
Cost of Revenue | 2K | 4K | -5.06M | -5.02M | -4.92M | 4.59M | 18.64M | 18.96M | 26.21M | 24.87M | 15.89M | 15.53M | 8.17M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 28.7M | 34.71M | 38.11M | 100.54M | 112.44M | 97.7M | 80.19M | 54.34M | 22.7M | 24.15M | 32.63M | -10.56M | -1.22M | 11.2M | 18.26M | 17.42M | 18.35M | 14.93M |
Operating Income | -57.49M | -74.11M | -73.36M | -1.1M | 15.55M | 21.73M | 21.48M | -3.13M | -13.03M | -26.22M | -42.2M | -95.62M | -106.31M | -98.78M | -87.97M | -79.27M | -75.76M | -75.69M |
Interest Income | 3.81M | 4.27M | 4.74M | 4.75M | 4.52M | 4.3M | 3.94M | 3.61M | 2.87M | 2M | 1.11M | 467K | 349K | 320K | 346K | 319K | 258K | 262K |
Pretax Income | -52.77M | -70.63M | -68.57M | 3.61M | 20.05M | 26M | 25.41M | 597K | -10.08M | -26.85M | -46.41M | -102.43M | -113.27M | -103.16M | -89.76M | -79.1M | -75.52M | -74.44M |
Net Income | -52.77M | -70.63M | -68.57M | 3.51M | 17.45M | 23.4M | 23.77M | -653K | -9.12M | -25.89M | -49.04M | -105.05M | -115.89M | -105.78M | -89.76M | -79.1M | -75.52M | -74.44M |
Selling & General & Admin | 24.96M | 24.61M | 23.7M | 23.08M | 23.59M | 24.15M | 25.55M | 25.62M | 26.54M | 28.5M | 36.48M | 43.01M | 47.53M | 48.71M | 41.7M | 36.18M | 30.34M | 25.65M |
Research & Development | 79.98M | 93.03M | 96.76M | 84.44M | 73.97M | 59.76M | 51.4M | 49.97M | 40.94M | 39.6M | 47.59M | 49.73M | 56.8M | 63.09M | 64.53M | 60.51M | 63.78M | 64.97M |
Other Expenses | -19.45M | -19.53M | -24.77M | -5.06M | 243K | 237K | 3.97M | 2.88M | -2.44M | -2.45M | -2.94M | -1.93M | -2M | -2.1M | -395K | -317K | -175K | -63K |
Operating Expenses | 85.49M | 98.11M | 95.69M | 102.46M | 97.8M | 82.22M | 79M | 76.55M | 62.21M | 63.66M | 79.15M | 88.89M | 101.42M | 109.98M | 106.23M | 96.68M | 94.11M | 90.62M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.4K | 2.4K | 119.4K | 2.61M | 4.54M | 4.54M | 4.43M | 1.94M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 68.86M | 98.11M | 100.76M | 107.56M | 102.91M | 87.33M | 79.04M | 76.55M | 62.21M | 63.66M | 79.15M | 88.89M | 101.42M | 109.98M | 106.23M | 96.68M | 94.11M | 90.62M |
Income Tax Expense | n/a | n/a | -91.75K | 5.25K | -1.92M | -1.92M | -2.79M | -3.18M | -988.02K | -875.02K | 2.71M | 2.71M | 2.64M | 2.45M | -270K | -270K | -209K | -213K |
Shares Outstanding (Basic) | 56.03M | 55.38M | 54.04M | 54.12M | 53.96M | 53.52M | 53M | 52.71M | 52.57M | 52.53M | 48.72M | 35.88M | 32.98M | 32.5M | 32.13M | 32.13M | 29.48M | 29.41M |
Shares Outstanding (Diluted) | 56.03M | 55.38M | 54.04M | 54.12M | 53.96M | 53.52M | 53.11M | 52.71M | 52.57M | 52.53M | 48.72M | 35.88M | 32.98M | 32.61M | 32.13M | 32.13M | 29.68M | 29.41M |
EPS (Basic) | -0.99 | -1.29 | -1.28 | 0.08 | 0.34 | 0.44 | 0.45 | 0.03 | -0.24 | -0.88 | -1.74 | -3.2 | -3.57 | -3.33 | -2.9 | -2.67 | -2.83 | -3.05 |
EPS (Diluted) | -0.99 | -1.29 | -1.28 | 0.07 | 0.33 | 0.43 | 0.44 | 0.03 | -0.24 | -0.88 | -1.74 | -3.2 | -3.57 | -3.33 | -2.9 | -2.67 | -2.83 | -3.05 |
EBITDA | -56.62M | -73.23M | -72.39M | 73.75K | 17.78M | 24.06M | 23.83M | -650K | -11.18M | -24.48M | -40.52M | -94.9M | -105.86M | -98.17M | -87.26M | -78.62M | -75.07M | -74.96M |
EBIT | -54.17M | -73.23M | -72.48M | -58K | 17.54M | 23.71M | 23.47M | -1.34M | -12.02M | -27.7M | -43.81M | -97.93M | -108.77M | -98.78M | -87.86M | -79.31M | -75.81M | -75.72M |
Depreciation & Amortization | 2K | 4K | 95.75K | 133.75K | 239.75K | 585.75K | 843K | 1.17M | 1.31M | 13.21M | 13.11M | 12.94M | 12.83M | 735K | 646K | 646K | 689K | 731K |